14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 82 days ( -7.69 % )
Last Price $0.700 0 %
High/ Low $0.700 - $0.700 0%
Chg 7 Days N/A $0.700 $0.700
Chg 30 Days N/A $0.700 $0.700
Chg 12 mos -59.77 % $1.74 $0.700
Trend - 3 mos -6.59 % Width: 322.91 %
Trend - 12 mos -23.20 % Width: 465.84 %
Pred. range - 3 mos $0.505 - $2.14 -27.79 % - 205.39 %
Pred. range - 12 mos N/A - $1.75 -100.00 % - 149.98 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Sep 13, 2023 - 51 days
Short/Long MA avg 3 mos Sell Sep 13, 2023 - 51 days
Short MA avg 12 mos Buy Jul 11, 2023 - 96 days
Long MA avg 12 mos Sell Aug 25, 2023 - 63 days
Short/Long MA avg 12 mos Sell Sep 25, 2023 - 44 days
Pivot Short Buy Aug 28, 2023 - 62 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Enochian Biosciences Inc.

Enochian Biosciences. Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV ... ENOB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT